-
Mashup Score: 3Science v. Ideology in Court: Mifepristone and the U.S. Food and Drug Administration | Annals of Internal Medicine - 1 month(s) ago
This commentary discusses the implications of a recent Texas federal district court ruling that halted the nationwide marketing of mifepristone. Not only will this ruling affect access to a safe an…
Source: www.acpjournals.orgCategories: General Medicine News, General HCPsTweet
Today, #SCOTUS heard a case threatening access to #mifepristone for miscarriage and #abortion. In a recent editorial, Wendy Mariner, JD, LLM, MPH said docs, not judges, should make decisions about patient care https://t.co/fa9LRgNxM0 @BUSPH @ABAesq @ASLMENews @BU_Law https://t.co/iKCqsUfgl5